PROTEASEVARIANTEN

European patent · EP2510093 · In force

Register entry

Publication number
EP2510093
Application number
EP10803307
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 10, 2010
Published
Oct 17, 2012
Granted
Feb 21, 2018
Protection ends at the latest
Dec 9, 2030
Next annual fee due
Dec 31, 2026
IPC classes
C12N 9/58 (2006.01)
Priority
US 285601 P 11.12.2009
PCT application
PCT/US2010/059814 10.12.2010
PCT publication
WO2011/072191 16.06.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Feb 21, 2018

    Granted

    Published in Swissreg on 21.02.2018

Parties

Holder

Novozymes A/S

Krogshoejvej 36, 2880 Bagsvaerd, DK

Novozymes North America, Inc.

77 Perry Chapel Church Road, Franklinton, North Carolina 27525, US

Inventor

MATSUI, Tomoko

Chiba 261-0001, JP

NOERGAARD, Allan

Chiba 272-0111, JP

POULSEN, Thomas, Agersten

DK-2750 Ballerup, DK

MATTHEWS, John

Louisburg North Carolina 27549, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.